RBM3
RNA-binding protein 3
Also known as: IS1-RNPL, RBM3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P98179
- Gene
- RBM3
- Ensembl
- ENSG00000102317
- Chromosome
- X
- Canonical length
- 157 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene is a member of the glycine-rich RNA-binding protein family and encodes a protein with one RNA recognition motif (RRM) domain. Expression of this gene is induced by cold shock and low oxygen tension. A pseudogene exists on chromosome 1. Multiple alternatively spliced transcript variants that are predicted to encode different isoforms have been characterized although some of these variants fit nonsense-mediated decay (NMD) criteria. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
157 residues, UniProt reviewed canonical sequence.
>P98179|RBM3
1 MSSEEGKLFV GGLNFNTDEQ ALEDHFSSFG PISEVVVVKD RETQRSRGFG FITFTNPEHA
61 SVAMRAMNGE SLDGRQIRVD HAGKSARGTR GGGFGAHGRG RSYSRGGGDQ GYGSGRYYDS
121 RPGGYGYGYG RSRDYNGRNQ GGYDRYSGGN YRDNYDNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBM3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 285 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 285 nTPM
- adipose tissue: 248 nTPM
- breast: 196 nTPM
- tonsil: 193 nTPM
- skin: 192 nTPM
- pancreas: 170 nTPM
Single-cell type
- extravillous trophoblasts: 873 nCPM
- megakaryocytes: 841 nCPM
- migrating cytotrophoblasts: 711 nCPM
- esophageal apical cells: 695 nCPM
- cytotrophoblasts: 521 nCPM
- hofbauer cells: 495 nCPM
Immune cell
- myeloid DC: 265 nTPM
- total PBMC: 257 nTPM
- intermediate monocyte: 213 nTPM
- non-classical monocyte: 188 nTPM
- classical monocyte: 188 nTPM
- plasmacytoid DC: 186 nTPM
Brain region
- spinal cord: 46 nTPM
- white matter: 46 nTPM
- hypothalamus: 44 nTPM
- medulla oblongata: 44 nTPM
- choroid plexus: 43 nTPM
- pons: 41 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.83
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of mRNA splicing, via spliceosome
- positive regulation of translation
- regulation of translation
- RNA processing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBM3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBM3 as an antibody target. Whether an autoantibody or antibody against RBM3 could matter depends on whether native RBM3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBM3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBM3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...